Company Filing History:
Years Active: 2018-2025
Title: Geraint Iwan Davies: Innovator in Drug Delivery Systems
Introduction
Geraint Iwan Davies is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of drug delivery systems, holding a total of nine patents. His work focuses on enhancing the efficiency and effectiveness of drug administration through innovative technologies.
Latest Patents
Among his latest patents is an injection monitoring device that provides drug delivery systems, devices, and methods for recording a drug dose completion signal in a data management system. This invention includes a syringe stopper rod equipped with a sensor component that features a wireless transmitter module. The activation component is designed to activate the sensor when the syringe stopper rod has completed a delivery stroke. The wireless transmitter module then transmits a report containing a drug dose completion signal upon activation. Another significant patent involves drug dosage determination devices and methods. This application relates to determining an administration regimen of a drug to a subject by computing the amount of drug to be administered per elemental period of time. It evaluates combinations of at least two dosage forms against different criteria, particularly for drugs administered routinely over prolonged periods.
Career Highlights
Geraint has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Roche Molecular Systems, Inc. His experience in these organizations has contributed to his expertise in drug delivery technologies and systems.
Collaborations
Throughout his career, Geraint has collaborated with notable professionals in the field, including Jorge Cancela Gonzalez and Jean-Philippe Guy Roger Guyon. These collaborations have further enriched his work and innovations.
Conclusion
Geraint Iwan Davies stands out as an influential inventor in the realm of drug delivery systems. His innovative patents and collaborations reflect his commitment to advancing healthcare technology. His contributions continue to impact the way drugs are administered and monitored, enhancing patient care and treatment outcomes.